RESTOR-MV

Principal Investigator:
Norbert Baumgartner MD (Covenant)

Sub Investigators:
Christopher Genco, MD
Peter Fattal, MD
Rao Gudipati, MD

Sponsor:
Myocor, Inc.

Study:
Randomized Evaluation of a Surgical Treatment for Off-pump Repair of the Mitral Valve

Objective:
To compare the safety and effectiveness of the Myocor Coapsys Annuloplasty System to open surgical repair of the mitral valve in patients with moderate to severe functional mitral regurgitation. The RESTOR-MV study is a prospective, randomized, multi-center trial comparing treatment of functional mitral regurgitation with Coapsys to open-heart surgical repair of the mitral valve.

Status:
Follow-up ONLY!

If you have any questions, please feel free to contact the coordinators, and they will be happy to answer any questions you have regarding this study.

<< Back